Literature DB >> 20360158

Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication.

Simon A Surguladze1, Elvina M Chu, Nicolette Marshall, Anthony Evans, Anantha P P Anilkumar, Clive Timehin, Colm McDonald, Christine Ecker, Mary L Phillips, Anthony S David.   

Abstract

We employed two event-related functional magnetic resonance imaging tasks using the pictures of mild and intense facial emotions of fear or happiness. The sample comprised 16 chronic schizophrenia patients treated with risperidone long-acting injections (RLAI), 16 patients treated with conventional antipsychotic depots (CONV) and 16 healthy controls (HC). The HC and RLAI groups demonstrated greater activation in the left amygdala in response to intensively fearful faces, and in right cerebellum to intensively happy faces compared with CONV patients. The CONV group demonstrated under-activation in the right temporal pole in response to intensively happy faces (compared with HC) and over-activation in ventro-medial prefrontal cortex (VMPFC) in response to both intensively happy and fearful expressions, compared with HC and RLAI groups. Our results suggest that networks implicated in the allocation of attentional resources (VMPFC) and emotion processing (amygdala, cerebellum) are differentially affected in patients on CONV versus RLAI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360158     DOI: 10.1177/0269881110363316

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  13 in total

Review 1.  Emotion and Theory of Mind in Schizophrenia-Investigating the Role of the Cerebellum.

Authors:  Omar Mothersill; Charlotte Knee-Zaska; Gary Donohoe
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

2.  Dopamine D4 receptor transmission in the prefrontal cortex controls the salience of emotional memory via modulation of calcium calmodulin-dependent kinase II.

Authors:  Nicole M Lauzon; Tasha Ahmad; Steven R Laviolette
Journal:  Cereb Cortex       Date:  2011-11-24       Impact factor: 5.357

Review 3.  A Review of the Functional and Anatomical Default Mode Network in Schizophrenia.

Authors:  Mao-Lin Hu; Xiao-Fen Zong; J John Mann; Jun-Jie Zheng; Yan-Hui Liao; Zong-Chang Li; Ying He; Xiao-Gang Chen; Jin-Song Tang
Journal:  Neurosci Bull       Date:  2016-12-19       Impact factor: 5.203

4.  Does baseline cerebral blood flow affect task-related blood oxygenation level dependent response in schizophrenia?

Authors:  Jiacheng Liu; Maolin Qiu; R Todd Constable; Bruce E Wexler
Journal:  Schizophr Res       Date:  2012-07-11       Impact factor: 4.939

5.  Meta-analysis of functional neuroimaging studies of emotion perception and experience in schizophrenia.

Authors:  Stephan F Taylor; Jian Kang; Inga S Brege; Ivy F Tso; Avinash Hosanagar; Timothy D Johnson
Journal:  Biol Psychiatry       Date:  2011-10-11       Impact factor: 13.382

6.  Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection.

Authors:  Wissam El-Hage; Simon A Surguladze
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

7.  Resting-state functional connectivity of the nucleus accumbens in auditory and visual hallucinations in schizophrenia.

Authors:  Benjamin Rolland; Ali Amad; Emmanuel Poulet; Régis Bordet; Alexandre Vignaud; Rémy Bation; Christine Delmaire; Pierre Thomas; Olivier Cottencin; Renaud Jardri
Journal:  Schizophr Bull       Date:  2014-07-21       Impact factor: 9.306

Review 8.  Long-acting injectable formulations of new-generation antipsychotics: a review from a clinical perspective.

Authors:  Anna-Sophia Rauch; W Wolfgang Fleischhacker
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

9.  Self-evaluation in schizophrenia: an fMRI study with implications for the understanding of insight.

Authors:  Nicholas J Bedford; Simon Surguladze; Vincent Giampietro; Michael J Brammer; Anthony S David
Journal:  BMC Psychiatry       Date:  2012-08-09       Impact factor: 3.630

Review 10.  The role of the cerebellum in schizophrenia: from cognition to molecular pathways.

Authors:  Peyman Yeganeh-Doost; Oliver Gruber; Peter Falkai; Andrea Schmitt
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.